Autor: |
Parati, G. Agabiti-Rosei, E. Bakris, G.L. Bilo, G. Branzi, G. Cecchi, F. Chrostowska, M. De La Sierra, A. Domenech, M. Dorobantu, M. Faria, T. Huo, Y. Jelaković, B. Kahan, T. Konradi, A. Laurent, S. Li, N. Madan, K. Mancia, G. McManus, R.J. Modesti, P.A. Ochoa, J.E. Octavio, J.A. Omboni, S. Palatini, P. Park, J.B. Pellegrini, D. Perl, S. Podoleanu, C. Pucci, G. Redon, J. Renna, N. Rhee, M.Y. Rodilla Sala, E. Sanchez, R. Schmieder, R. Soranna, D. Stergiou, G. Stojanovic, M. Tsioufis, K. Valsecchi, M.G. Veglio, F. Waisman, G.D. Wang, J.G. Wijnmaalen, P. Zambon, A. Zanchetti, A. Zhang, Y. |
Jazyk: |
angličtina |
Rok vydání: |
2018 |
Popis: |
Introduction Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. Methods and analysis MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hypertensive patients from about 40 secondary care clinical centres worldwide will be included -upon confirming presence of MUCH (repeated on treatment OBP |
Databáze: |
OpenAIRE |
Externí odkaz: |
|